Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Market Cap$912.06M
Close$
$0.18
94.3% downside
Current Fair Value
94.3% downsideOvervalued by 94.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $912.06 Million |
|---|---|
| Enterprise Value | $1.18 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 1.63 |
| Outstanding Shares | 247,170,648 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | - |
| Price to Book Ratio | 3.07 |
| Enterprise Value to Revenue | 693.72 |
| Enterprise Value to EBIT | -10.42 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Nuvation Bio Inc
36 employeesNuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically ...